Does LISINOPRIL Cause Product formulation issue? 12 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Product formulation issue have been filed in association with LISINOPRIL (Lisinopril). This represents 0.0% of all adverse event reports for LISINOPRIL.
12
Reports of Product formulation issue with LISINOPRIL
0.0%
of all LISINOPRIL reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product formulation issue From LISINOPRIL?
Of the 12 reports, 1 (8.3%) required hospitalization, and 2 (16.7%) were considered life-threatening.
Is Product formulation issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LISINOPRIL. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does LISINOPRIL Cause?
Angioedema (5,370)
Drug hypersensitivity (3,779)
Cough (2,527)
Completed suicide (2,246)
Drug ineffective (2,208)
Acute kidney injury (2,022)
Dyspnoea (1,856)
Dizziness (1,758)
Hypotension (1,750)
Fatigue (1,549)
What Other Drugs Cause Product formulation issue?
MINOXIDIL (1,369)
LEVOTHYROXINE (740)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (174)
OMEPRAZOLE (99)
METHYLPHENIDATE (78)
OXYCODONE (73)
ACETAMINOPHEN\HYDROCODONE (62)
ACETAMINOPHEN\OXYCODONE (61)
ACETAMINOPHEN (59)
BUPROPION (59)
Which LISINOPRIL Alternatives Have Lower Product formulation issue Risk?
LISINOPRIL vs LISOCABTAGENE MARALEUCEL
LISINOPRIL vs LITHIUM
LISINOPRIL vs LIXISENATIDE
LISINOPRIL vs LOBAPLATIN
LISINOPRIL vs LOFEXIDINE